</body> Date: Thursday May 15th Time: 4:00 pm GMT (UK) | 11:00 am EST PathXL’s proprietary tumor detection software, TissueMark®, has been evolving rapidly since its launch in November 2013 and we are glad to announce a range of...

TUCSON, Ariz., Oct. 24, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm HER2...